Generation Bio Co.
GBIO
$0.3901
$0.01584.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -39.63% | 25.05% | 72.59% | -111.85% | -24.48% |
| Total Depreciation and Amortization | -0.34% | -6.57% | -3.73% | -0.98% | 2.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.71% | -22.03% | -94.52% | 1,598.90% | -1.60% |
| Change in Net Operating Assets | 88.95% | -41.99% | 67.33% | -414.00% | 480.53% |
| Cash from Operations | 19.25% | 9.23% | 32.06% | -26.90% | -0.33% |
| Capital Expenditure | -315.38% | -550.00% | 99.27% | 58.12% | -650.82% |
| Sale of Property, Plant, and Equipment | 4.44% | -56.73% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 453.67% | 6.28% | 779.12% | -48.80% | 110.26% |
| Cash from Investing | 453.07% | 5.11% | 2,286.26% | 71.11% | 92.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,115.38% | -95.09% | -- | -- | -- |
| Repurchase of Common Stock | 12.50% | 48.39% | 75.20% | -6.84% | 10.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,900.00% | -101.28% | 287.20% | -262.34% | 158.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 898.66% | 25.72% | 71.55% | -20.73% | 48.04% |